Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paraskevi V Voulgari

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Annals of Gastroenterology|April 10, 2014
Rheumatological manifestations in inflammatory bowel diseaseParaskevi V Voulgari
Expert Review of Clinical Immunology|September 11, 2010
Golimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitisParaskevi V Voulgari
Expert Opinion on Emerging Drugs|March 7, 2008
Emerging drugs for rheumatoid arthritisParaskevi V Voulgari
Mediterranean Journal of Rheumatology|February 20, 2025
Exploring the Cutting Edge: A Recap of EULAR & ACR 2023 Highlights for Spondyloarthritis, including Psoriatic ArthritisNafsika Gerolymatou, Paraskevi V Voulgari
Expert Opinion on Biological Therapy|January 17, 2007
Adalimumab for rheumatoid arthritisParaskevi V Voulgari, Alexandros A Drosos
Expert Opinion on Biological Therapy|March 5, 2014
Adalimumab in the treatment of rheumatoid arthritisParaskevi V Voulgari, Alexandros A Drosos
Mediterranean Journal of Rheumatology|May 8, 2026
Optimising Conventional Therapy in Rheumatoid ArthritisAlexandros A Drosos, Paraskevi V Voulgari
Open Access Rheumatology : Research and Reviews|May 18, 2009
Long-term use of adalimumab in the treatment of rheumatic diseasesCharalampos Papagoras, Paraskevi V Voulgari, Alexandros A Drosos
Seminars in Arthritis and Rheumatism|October 19, 2006
Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic reviewYannis Alamanos, Paraskevi V Voulgari, Alexandros A Drosos
Expert Opinion on Biological Therapy|January 20, 2018
ABP 501 for the treatment of rheumatoid arthritisEleftherios Pelechas, Paraskevi V Voulgari, Alexandros A Drosos
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Annals of Gastroenterology|April 10, 2014
Rheumatological manifestations in inflammatory bowel diseaseParaskevi V Voulgari
Expert Review of Clinical Immunology|September 11, 2010
Golimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitisParaskevi V Voulgari
Expert Opinion on Emerging Drugs|March 7, 2008
Emerging drugs for rheumatoid arthritisParaskevi V Voulgari
Mediterranean Journal of Rheumatology|February 20, 2025
Exploring the Cutting Edge: A Recap of EULAR & ACR 2023 Highlights for Spondyloarthritis, including Psoriatic ArthritisNafsika Gerolymatou, Paraskevi V Voulgari
Expert Opinion on Biological Therapy|January 17, 2007
Adalimumab for rheumatoid arthritisParaskevi V Voulgari, Alexandros A Drosos
Expert Opinion on Biological Therapy|March 5, 2014
Adalimumab in the treatment of rheumatoid arthritisParaskevi V Voulgari, Alexandros A Drosos
Mediterranean Journal of Rheumatology|May 8, 2026
Optimising Conventional Therapy in Rheumatoid ArthritisAlexandros A Drosos, Paraskevi V Voulgari
Open Access Rheumatology : Research and Reviews|May 18, 2009
Long-term use of adalimumab in the treatment of rheumatic diseasesCharalampos Papagoras, Paraskevi V Voulgari, Alexandros A Drosos
Seminars in Arthritis and Rheumatism|October 19, 2006
Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic reviewYannis Alamanos, Paraskevi V Voulgari, Alexandros A Drosos
Expert Opinion on Biological Therapy|January 20, 2018
ABP 501 for the treatment of rheumatoid arthritisEleftherios Pelechas, Paraskevi V Voulgari, Alexandros A Drosos
Pageof 21